| Clinical Trial | No.
of patients |
Disease | Cell Type | Time
of transplantation |
Route
of transplantation |
Functional
Outcome |
| Phase I | 12 | Basal ganglia infarcts | Human NT2/D1 | Mean: 27 months | Intraparenchymal | Some improvement |
| Phase II | 12 | Ischaemic/ hemorrhagic | Human NT2/D1 | Mean: 3.5 years | Intraparenchymal | Some improvement |
| Phase I/II | 30 | Mid cerebral artery infarc | Mesenchymal | 4–9 weeks | Intravenous | Improved |